Chronic Intrathecal Administration of Dexamethasone Sodium Phosphate: Pharmacokinetics and Neurotoxicity in an Animal Model
Authors:
Open Access
- 1 January 2000
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 46 (1) , 178-183
Abstract
Although corticosteroids have been used intraspinally for many years, long-term intrathecal administration has not been examined. We have assessed the stability, bioavailability, and safety of continuously delivering the prodrug dexamethasone sodium phosphate into the lumbar subarachnoid space. High-performance liquid chromatography studies were performed to determine whether dexamethasone sodium phosphate is degraded either in vials or in an infusion pump at 37°C during a period of weeks. Rats then received implants with a combined intrathecal delivery and microdialysis sampling catheter to determine whether the prodrug is converted to free dexamethasone. A neurotoxicity study was performed in which rats received implants with an intrathecal catheter and were continuously infused with the corticosteroid during a 2-week period. Dexamethasone sodium phosphate, diluted in saline, is stable at body temperature in vials and implantable infusion pumps for at least 2 weeks. When delivered into the cerebrospinal fluid as a bolus, virtually all of the prodrug is converted to free dexamethasone within 40 minutes. When administered continuously, most of the corticosteroid is in its active form at steady state. Low doses of corticosteroid (≤12.5 ng/h) produced no side effects or neuropathology in the rats, but a higher dose (125 ng/h) was associated with inflammation in the lumbar subarachnoid space. Dexamethasone sodium phosphate is a stable prodrug that is efficiently converted to free dexamethasone when delivered intrathecally. Low continuous intrathecal doses seem safe, but higher doses may lead to increased inflammation.Keywords
This publication has 16 references indexed in Scilit:
- The spinal loop dialysis catheter: characterization of use in the unanesthetized ratJournal of Neuroscience Methods, 1995
- Intrathecal steroids to reduce pain after lumbar disc surgery: a double-blind, placebo-controlled prospective studyPain, 1995
- Pilot Study of the Pharmacokinetics of Methylprednisolone After Single and Multiple Intravenous Doses of Methylprednisolone Sodium Succinate and Methylprednisolone Suleptanate to Healthy VolunteersThe Journal of Clinical Pharmacology, 1994
- Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosaJournal of Neurosurgery, 1993
- The Effect of Intrathecal Dexamethasone Injection on Plasma Cortisol LevelRheumatology, 1991
- Two Chromatographic Methods for the Determination of Corticosteroids in Human Biological Fluids: Pharmacokinetic ApplicationsJournal of Pharmaceutical Sciences, 1989
- Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia.Journal of Clinical Oncology, 1987
- Intraspinal steroid therapyNeurology, 1981
- Bioavailability of dexamethasone; II. Dexamethasone phosphateClinical Pharmacology & Therapeutics, 1975
- Intrathecal toxicity studies with benzyl alcoholToxicology and Applied Pharmacology, 1973